Arsenal Biosciences, Inc. raised $325 million in a Series C funding round led by ARCH Venture Partners to advance programmable cell therapy programs through clinical development.
Amount Raised
$325 Million
Round Type
Series C
South San FranciscoBiotechnologyHealth CareTherapeuticsInvestors
Description
Arsenal Biosciences, Inc. announced the close of an oversubscribed $325 million Series C financing round to support its advanced CAR T-cell therapy programs. The funding will be used to develop its therapeutic pipeline for solid tumor cancers and enhance innovation in cell therapy.
Quick answer
Arsenal Biosciences raised $325 Million in a Series C round, dated September 4, 2024. Investors: Hitachi Ventures, Byers Capital, Kleiner Perkins, Westlake Village Bio Partners, Bristol Myers Squibb Company, Soft Bank Vision Fund 2, Parker Institute For Cancer Immunotherapy and Rock Springs Capital. Arsenal Biosciences is based in South San Francisco, California, United States.
- How much did Arsenal Biosciences raise?
- Arsenal Biosciences raised $325 Million in a Series C round on September 4, 2024.
- Who invested in Arsenal Biosciences?
- Hitachi Ventures, Byers Capital, Kleiner Perkins, Westlake Village Bio Partners, Bristol Myers Squibb Company, Soft Bank Vision Fund 2, Parker Institute For Cancer Immunotherapy and Rock Springs Capital are named as investors in this round.
- What does Arsenal Biosciences do?
- Arsenal Biosciences, Inc. (ArsenalBio), headquartered in South San Francisco, Calif., is a privately held programmable cell therapy company discovering and developing a pipeline of next-generation autologous T cell..
- Where is Arsenal Biosciences based and how big is it?
- Arsenal Biosciences is based in South San Francisco, California, United States.
- Who are the decision-makers at Arsenal Biosciences?
- Fundz holds 1 contact at Arsenal Biosciences, including the Chairman, CEO, Co-Founder. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Arsenal Biosciences that raised within 45 days of this round, from Fundz verified event records.
- TenNor Therapeutics raised $41M (Series E) on October 16, 2024.
- Tolerance Bio raised $17M (Seed) on October 15, 2024.
- invIOs raised $8.9M (Series A) on October 15, 2024.
- Antiverse raised $4.6M (Seed) on October 15, 2024.
- Shift Bioscience raised $16M (Seed) on October 15, 2024.
- NewcelX raised $7.2M on October 11, 2024.
Who to call at Arsenal Biosciences, and when
A new round usually means Arsenal Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Arsenal Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Arsenal Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Arsenal Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Arsenal Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Arsenal Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.